These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27786011)

  • 1. Enalapril Treatment in a Patient With Impaired Renal Function and Intolerance to Captopril.
    Lindsjö M; Danielson BG; Weiss L; Wikström B
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):99-102. PubMed ID: 27786011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
    Lindsjö M; Danielson BG; Weiss L; Wikström B
    Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
    Thind GS
    J Clin Hypertens; 1985 Dec; 1(4):337-43. PubMed ID: 3014079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Captopril and enalapril in the treatment of renal hypertension].
    Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G
    Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
    J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of patch tests for diagnosing selective allergy to captopril.
    Gaig P; San Miguel-Moncin MM; Bartra J; Bonet A; García-Ortega P
    J Investig Allergol Clin Immunol; 2001; 11(3):204-6. PubMed ID: 11831455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1997 Jul; 29(3):317-28. PubMed ID: 9267040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.